Table 1 Clinical characteristics of Cedars-Sinai Medical Center study cohort, reported per echocardiography study

From: Vision–language foundation model for echocardiogram interpretation

 

Total

Training

Validation

Test

n

224,685

195,082

8,119

21,484

Age (mean (s.d.))

66.26 (16.74)

66.3 (16.7)

65.8 (17.0)

65.7 (16.9)

Female = true (%)

96,451 (42.9)

83,700 (42.9)

3,363 (41.4)

9,388 (43.7)

Race (%)

Native American

526 (0.2)

456 (0.2)

23 (0.3)

47 (0.2)

Asian

16,601 (7.5)

14,450 (7.5)

555 (6.9)

1,596 (7.5)

Black

29,546 (13.3)

25,624 (13.3)

1,104 (13.8)

2,818 (13.3)

Hispanic

22,424 (10.1)

19,394 (10.0)

842 (10.5)

2,188 (10.3)

Non-Hispanic white

133,399 (60.0)

116,044 (60.1)

4,699 (58.6)

12,656 (59.6)

Other

15,376 (6.9)

13,243 (6.9)

612 (7.6)

1,521 (7.2)

Pacific Islander

767 (0.3)

688 (0.4)

36 (0.4)

43 (0.2)

Unknown

3,700 (1.7)

3,182 (1.6)

149 (1.9)

369 (1.7)

AF

46,994 (20.9)

41,214 (21.1)

1,633 (20.1)

4,147 (19.3)

HF

75,358 (33.5)

65,802 (33.7)

2,764 (34.0)

6,792 (31.6)

HTN

90,738 (40.4)

79,229 (40.6)

3,250 (40.0)

8,259 (38.4)

CVA/TIA/TE

38,283 (17.0)

33,475 (17.2)

1,378 (17.0)

3,430 (16.0)

MI

14,983 (6.7)

13,120 (6.7)

514 (6.3)

1,349 (6.3)

CAD

55,659 (24.8)

48,840 (25.0)

2,040 (25.1)

4,779 (22.2)

PAD

23,369 (10.4)

20,475 (10.5)

838 (10.3)

2,056 (9.6)

DM

37,900 (16.9)

33,226 (17.0)

1,351 (16.6)

3,323 (15.5)

CKD

40,947 (18.2)

35,960 (18.4)

1,482 (18.3)

3,505 (16.3)

Previous smoker

7,632 (3.4)

6,593 (3.4)

256 (3.2)

783 (3.6)

  1. AF, atrial fibrillation; HF, heart failure; HTN, hypertension; CVA, cerebrovascular accident; TIA, transient ischemic attack; TE, thromboembolism; MI, myocardial infarction; CAD, coronary artery disease; PAD, pulmonary artery disease; DM, diabetes mellitus; CKD, chronic kidney disease.